Camille Sureau，巴黎，法国——HBV相关实验室及人物介绍系列
Camille Sureau，巴黎，法国——HBV相关实验室及人物介绍系列Camille Sureau，INSERM，巴黎，法国
Verrier, E. R. and C. C. Colpitts, et al. (2016). "Hepatitis B virus receptors and molecular drug targets." Hepatol Int.
Sureau, C. and F. Negro (2016). "The hepatitis delta virus: Replication and pathogenesis." J Hepatol 64(1 Suppl): S102-16.
Verrier, E. R. and C. C. Colpitts, et al. (2016). "A targeted functional RNA interference screen uncovers glypican 5 as an entry factor for hepatitis B and D viruses." Hepatology 63(1): 35-48.
Kaneko, M. and K. Watashi, et al. (2015). "A Novel Tricyclic Polyketide, Vanitaracin A, Specifically Inhibits the Entry of Hepatitis B and D Viruses by Targeting Sodium Taurocholate Cotransporting Polypeptide." J Virol 89(23): 11945-53.
Julithe, R. and G. Abou-Jaoude, et al. (2014). "Modification of the hepatitis B virus envelope protein glycosylation pattern interferes with secretion of viral particles, infectivity, and susceptibility toneutralizing antibodies." J Virol 88(16): 9049-59.
Sureau, C. and J. Salisse (2013). "A conformational heparan sulfate binding site essential to infectivity overlaps with the conserved hepatitis B virus a-determinant." Hepatology 57(3): 985-94.
Servant-Delmas, A. and M. Mercier-Darty, et al. (2012). "Variable capacity of 13 hepatitis B virus surface antigen assays for the detection of HBsAg mutants in blood samples." J Clin Virol 53(4): 338-45.
Mercier, M. and S. Laperche, et al. (2011). "Overestimation of incidence of hepatitis B virus mixed-genotype infections by use of the new line probe INNO-LiPA genotyping assay." J Clin Microbiol 49(3): 1154-6.
Salisse, J. and C. Sureau (2009). "A function essential to viral entry underlies the hepatitis B virus "a" determinant." J Virol 83(18): 9321-8.
Le Duff, Y. and M. Blanchet, et al. (2009). "The pre-S1 and antigenic loop infectivity determinants of the hepatitis B virus envelope proteins are functionally independent." J Virol 83(23): 12443-51.
Abou-Jaoude, G. and C. Sureau (2007). "Entry of hepatitis delta virus requires the conserved cysteine residues of the hepatitis B virus envelope protein antigenic loop and is blocked by inhibitors of thiol-disulfide exchange." J Virol 81(23): 13057-66.
Blanchet, M. and C. Sureau (2007). "Infectivity determinants of the hepatitis B virus pre-S domain are confined to the N-terminal 75 amino acid residues." J Virol 81(11): 5841-9.
Blanchet, M. and C. Sureau (2006). "Analysis of the cytosolic domains of the hepatitis B virus envelope proteins fortheir function in viral particle assembly and infectivity." J Virol 80(24): 11935-45.
Komla-Soukha, I. and C. Sureau (2006). "A tryptophan-rich motif in the carboxyl terminus of the small envelope protein of hepatitis B virus is central to the assembly of hepatitis delta virus particles." J Virol 80(10): 4648-55.
Jaoude, G. A. and C. Sureau (2005). "Role of the antigenic loop of the hepatitis B virus envelope proteins in infectivity of hepatitis delta virus." J Virol 79(16): 10460-6.
Sureau, C. and C. Fournier-Wirth, et al. (2003). "Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus." J Virol 77(9): 5519-23.
共同发展！学习才会进步，谢了
页:
[1]